Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor–or Progesterone Receptor–Positive Breast Cancer

INTRODUCTION: Tumor content or expression of vascular endothelial growth factor (VEGF) is associated with impaired efficacy of antiestrogen adjuvant therapy. We designed a pilot study to assess the feasibility and short-term efficacy of neoadjuvant letrozole and bevacizumab (anti-VEGF) in postmenopa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Breast Cancer
Main Authors: Forero-Torres, Andres, Saleh, Mansoor N., Galleshaw, Janice A., Jones, Cheryl F., Shah, Jatin J., Percent, Ivor J., Nabell, Lisle M., Carpenter, John T., Falkson, Carla I., Krontiras, Helen, Urist, Marshall M., Bland, Kirby I., De Los Santos, Jennifer F., Meredith, Ruby F., Caterinicchia, Valerie, Bernreuter, Wanda K., O'Malley, Janis P., Li, Yufeng, LoBuglio, Albert F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451110/
https://ncbi.nlm.nih.gov/pubmed/20705559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados